Professor of Medicine, Ohio State University
Endocrinology
Dr. Kwame Osei, MD
|
|
Give Review
Kwame Osei works in the field of Endocrinology. He went to University of Ghana Medical School. He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACP)". Doctor Kwame Osei, MD is a published doctor as well. He has 101 publications published. The latest was: Minimal model analyses of insulin sensitivity and glucose-dependent glucose disposal in black and white Americans: a study of persons at risk for type 2 diabetes. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Racial Disparities in the Pathogenesis of Type 2 Diabetes and its Subtypes in the African Diaspora: A New Paradigm.
- Mathematical analysis of a model for glucose regulation.
- GlycA is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients with Type 2 Diabetes.
- Comparative Study of Glucose Homeostasis, Lipids and Lipoproteins, HDL Functionality, and Cardiometabolic Parameters in Modestly Severely Obese African Americans and W...
- Does oral supplementation of a fermented papaya preparation correct respiratory burst function of innate immune cells in type 2 Diabetes mellitus patients?
- A comparison of continuous intravenous insulin and subcutaneous insulin among patients with type 2 Diabetes and congestive heart failure exacerbation.
- Exercise-mediated changes in high-density lipoprotein: Impact on form and function.
- Prandial Insulin Dosing Using the Carbohydrate Counting Technique in Hospitalized Patients With Type 2 Diabetes.
- Effect of the approach to insulin therapy on glycaemic fluctuations and autonomic tone in hospitalized patients with Diabetes.
- Exenatide pretreatment improved graft function in nonhuman primate islet recipients compared to treatment after transplant only.
- Characterization of metabolically unhealthy overweight/obese African American women: significance of insulin-sensitive and insulin-resistant phenoTypes.
- Correction of Aberrant NADPH Oxidase Activity in Blood-Derived Mononuclear Cells from Type II Diabetes Mellitus Patients by a Naturally Fermented Papaya Preparation.
- Proinsulin atypical maturation and disposal induces extensive defects in mouse Ins2+/Akita β-cells.
- β-Cells With relative low HIMP1 overexpression levels in a transgenic mouse line enhance basal insulin production and hypoxia/hypoglycemia tolerance.
- Cardiovascular effects of type 1 Diabetes mellitus in children.
- Discrepancies in the regulation of plasma adiponectin and TNF-alpha levels and adipose tissue gene expression in obese African Americans With glucose intolerance: a pi...
- Long-term safety of pioglitazone versus glyburide in patients with recently diagnosed type 2 Diabetes mellitus.
- Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 Diabetes: African American triglycerides-HDL-C and insulin re...
- Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 Diabetes mellitus. A pilot study of rosiglitazone.
- Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
- Association between glycosylated hemoglobin, left ventricular mass and aortic function in nondiabetic individuals With insulin resistance.
- Importance of aerobic fitness in cardiovascular risks in sedentary overweight and obese African-American women.
- The cardiometabolic Syndrome in persons of the African diaspora: challenges and opportunities.
- Comparison of the portal vein and kidney subcapsule as sites for primate islet autotransplantation.
- Comparison of dietary conjugated linoleic acid with safflower oil on body composition in obese postmenopausal women with type 2 Diabetes mellitus.
- Metabolic Syndrome in Black people of the African diaspora: the paradox of current classification, definition and criteria.
- Constructing common cohorts from trials With overlapping eligibility criteria: implications for comparing effect sizes between trials.
- Differential impact of serum glucose, triglycerides, and high-density lipoprotein cholesterol on cardiovascular risk factor burden in nonDiabetic, obese African Americ...
- Independent role of blood pressure on cardiovascular risk factors in nondiabetic, obese African-American women with family history of type 2 Diabetes: Implications for...
- Metabolic Syndrome in blacks: are the criteria right?
- Relationship between glycemic control and readmission rates in patients hospitalized With congestive heart failure during implementation of hospital-wide initiatives.
- 25-OH vitamin D: is it the universal panacea for metabolic syndrome and type 2 Diabetes?
- New recommendations for treating hypertension in black patients: evidence and/or consensus?
- The effect of glycaemic control and glycaemic variability on mortality in patients hospitalized With congestive heart failure.
- HDL dysfunctionality (Paraoxonase) is worse in nonDiabetic, postmenopausal African American than in white women.
- Comparison of 3 algorithms for Basal insulin in transitioning from intravenous to subcutaneous insulin in stable patients after cardiothoracic surgery.
- Control of precursor maturation and disposal is an early regulative mechanism in the normal insulin production of pancreatic ?-cells.
- Steroid-free maintenance of islet allografts using mycophenolate mofetil and cyclosporine in the non-human primate.
- Proinsulin maturation disorder is a contributor to the defect of subsequent conversion to insulin in ?-cells.
- Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 Diabetes?
- Beneficial metabolic effects of chronic glipizide in obese African Americans with impaired glucose tolerance: implications for primary prevention of type 2 Diabetes.
- Ragaglitazar improves glycemic control and lipid profile in Type 2 diabetic subjects: a 12-week, double-blind, placebo-controlled dose-ranging study with an open piogl...
- Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 Diabetes in pre-diabetic...
- Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and Type ...
- Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 Diabetes.
- Pathogenic mechanism of type 2 Diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
- Patient survival after renal transplantation: IV. Impact of post-transplant Diabetes.
- Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians With varying degrees of glucose tolerance.
- Diabetes in Africa. Pathogenesis of type 1 and type 2 Diabetes mellitus in sub-Saharan Africa: implications for transitional populations.
- Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals With insulin resistance: double blind, prospective randomized study.
- Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in ...
- Global epidemic of type 2 Diabetes: implications for developing countries.
- Substrate-favored lysosomal and proteasomal pathways participate in the normal balance control of insulin precursor maturation and disposal in ?-cells.
- The impact of an insulin sensitizer, troglitazone, on glucose Metabolism in African Americans at risk for type 2 diabetes mellitus: a placebo-controlled, 24-month rand...
- Insulin sensitivity and cardiovascular risk factors in hypertensive and normotensive native Ghanaians.
- Long term cardiovascular effects of oral antidiabetic agents in non-diabetic patients With insulin resistance: double blind, prospective, randomised study.
- Effect on glycemic control of the addition of 2.5 mg glipizide GITS to metformin in patients With T2DM.
- Differential response between Diabetes and stress-induced hyperglycaemia to algorithmic use of detemir and flexible mealtime aspart among stable postcardiac surgery pa...
- Pancreatic exocrine "burnout" following pancreas transplantation.
- The effects of superphysiologic hyperinsulinemia on glucose and lipid Metabolism in glucose-tolerant offspring of patients with non-insulin-dependent diabetes mellitus...
- Insulin insensitivity and glucose effectiveness in Type I diabetic allograft pancreas recipients.
- Sequential metabolic studies of pancreas allograft function in Type 1 diabetic recipients.
- Differences in basal and poststimulation glucose homeostasis in nondiabetic first degree relatives of black and white patients with type 2 Diabetes mellitus.
- Minimal model analysis of insulin sensitivity and glucose-mediated glucose disposal in Type 1 (insulin-dependent) diabetic pancreas allograft recipients.
- Insulin sensitivity, glucose effectiveness, and body fat distribution pattern in nondiabetic offspring of patients With NIDDM.
- Hypoglycemia after successful pancreas transplantation in Type I diabetic patients.
- The use of continuous subcutaneous octreotide infusion in brittle Type 1 diabetic patients.
- Relationships of obesity indices to serum insulin and lipoproteins in relatives of black patients with noninsulin-dependent Diabetes mellitus (NIDDM).
- Continuous subcutaneous octreotide infusion: dose-response relationships between metabolic effects and octreotide clearance in patients with insulin-dependent (Type 1)...
- Increased basal glucose production and utilization in nondiabetic first-degree relatives of patients With NIDDM.
- Physiological and pharmacological stimulation of pancreatic islet hormone secretion in Type I diabetic pancreas allograft recipients.
- Predicting type II Diabetes in persons at risk.
- Dietary fructose as a natural sweetener in poorly controlled type 2 diabetes: a 12-month crossover study of effects on glucose, lipoprotein and apolipoprotein Metabolism.
- Metabolic effects of long-acting somatostatin analogue (sandostatin) in Type I diabetic patients on conventional therapy.
- Defective insulin-mediated splanchnic glucose regulation and glucose clearance: early glucose homeostatic defects in nondiabetic, young offspring of patients With noni...
- Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones.
- Chronic hyponatremia associated With diabetic amyotrophy.
- Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in Type II diabetic patients.
- Clinical evaluation of determinants of glycemic control. A new approach using serum glucose, C-peptide, and body mass indexes in Type II diabetic patients.
- The effects of carbohydrate-enriched meals on glucose turnover and metabolic clearance rates of glucose in Type 2 diabetic patients.
- Altered C-peptide/insulin molar ratios and glucose turnover rates after stimulation in nondiabetic offsprings of Type II diabetic patients.
- Ambulatory and exercise-induced blood pressure responses in Type I diabetic patients and normal subjects.
- Metabolic effects of fructose as a natural sweetener in the physiologic meals of ambulatory obese patients with type II Diabetes.
- The role of splanchnic glucose output in determining glycemic responses after mixed meal in Type II diabetic patients and normal subjects.
- Clinical correlates of basal hepatic glucose output and metabolic clearance rate of glucose using glucose-C-peptide-body mass indexes in ambulatory Type 2 diabetic pat...
- Coexistence of Diabetes mellitus, optic atrophy, and sensorineural deafness: case report.
- Indapamide. Effects on apoprotein, lipoprotein, and glucoregulation in ambulatory Diabetic patients.
- Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in Hyperthyroidism.
- Serum C-peptide levels determine glycemic responses in Type II diabetic patients treated with combined insulin and sulfonylurea agent.
- Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein Metabolism and glucoregulation.
- Abnormal retinal artery responses to stress in patients with type I Diabetes.
- Pregnancy complicated by insulinoma.
- Clinical features, diagnosis and management of insulinoma in 16 consecutive patients: cost-ineffectiveness of non-invasive imaging modalities.
- Empyema due to Salmonella typhimurium With underlying alveolar cell carcinoma.
- Diabetogenic effect of pentamidine. In vitro and in vivo studies in a patient With malignant insulinoma.
- Significance of spontaneous ketonuria and serum C-peptide levels in obese Type II diabetic patients.
- Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperThyroid patients.
- Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid Metabolism.
- Primary Adrenal insufficiency manifesting as malignant lymphoma.
- Minimal model analyses of insulin sensitivity and glucose-dependent glucose disposal in black and white Americans: a study of persons at risk for type 2 Diabetes.
Schools
University Of Ghana Medical School
University Ghana Tchg Hospital
Episcopal Hospital
Hahnemann Hospital
Ohio State University Hospital
Conditions Treated
- Adrenal Insufficiency
- Calcium Metabolism Disorders
- Diabetes Type 1
- Diabetes Type 2
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACP)
Education
-
Ohio State University Hospital -
Drexel University - Hahnemann University Hospital -
University of Ghana Medical School
Hospital
-
Ohio State University Wexner Medical Center
Drug Facts
| NPI NUMBER | 1912914029 | |
| NPPES Provider LastName | OSEI | |
| NPPES Provider FirstName | KWAME | |
| NPPES Provider ZIPCode | 432101240 | |
| NPPES Provider State | OH | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 1844.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 42.0 | |
| Percent Opioid Claims | 2.28 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1912914029 |
| Last Name Of The Provider | OSEI |
| First Name Of The Provider | KWAME |
| View All |
Similar Doctors
|
Dr. John D. Blackman, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Leslie K. Hoffman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rundsarah M. Tahboub, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shumei Meng, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Matthew D. Ringel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nora Alghothani, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael S. Berk, OD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lawrence S. Kirschner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aruna A. Suresh, MD
This Doctor is OpenDoctor Recommended.
|